Trials / Completed
CompletedNCT02566226
Impact of Intrathecal Morphine on Sleep Apnea Syndrome
Impact of Intrathecal Morphine on Sleep Apnea Syndrome After Hip Arthroplasty Performed Under Spinal Anaesthesia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Centre Hospitalier Universitaire Vaudois · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Intrathecal morphine is commonly used as an analgesic adjunct for hip arthroplasty performed under spinal anaesthesia. Sleep apnea syndrome is a condition that affects up to 10% of the patients. Effect of intrathecal hydrophilic opioids on the frequency and duration of apneic episodes is unknown. The objective of this randomised controlled trial is to investigate the effect of intrathecal morphine and surgery on apneic episodes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine with normal saline | Isobaric bupivacaine 15 mg + normal saline 0.5 cc |
| DRUG | Bupivacaine with intrathecal morphine | Isobaric bupivacaine 15 mg + intrathecal morphine 100 mcg |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2015-10-02
- Last updated
- 2019-11-04
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02566226. Inclusion in this directory is not an endorsement.